{"pub_date": "2016-02-12T00:00:00Z", "subsection_name": "DealBook", "lead_paragraph": "The drug maker Mylan, which rejected one offer and was itself rebuffed on another, may be overpaying for the Swedish company Meda.", "print_page": null, "document_type": "article", "byline": {"person": [{"rank": 1, "organization": "", "lastname": "CYRAN", "firstname": "Robert", "role": "reported"}], "original": "By ROBERT CYRAN"}, "multimedia": [], "section_name": "Business Day", "headline": {"content_kicker": "Breakingviews", "main": "Mylan\u2019s New Deal May Not Be the One Shareholders Wanted", "kicker": "Breakingviews"}, "source": "The New York Times", "blog": [], "word_count": "343", "web_url": "http://www.nytimes.com/2016/02/12/business/dealbook/mylans-new-deal-may-not-be-the-one-shareholders-wanted.html", "slideshow_credits": null, "news_desk": "Business", "type_of_material": "News", "snippet": "The drug maker Mylan, which rejected one offer and was itself rebuffed on another, may be overpaying for the Swedish company Meda.", "_id": "56bce0f738f0d810e6a1a1c3", "abstract": null, "keywords": [{"rank": "1", "name": "subject", "value": "Mergers, Acquisitions and Divestitures", "is_major": "N"}, {"rank": "2", "name": "organizations", "value": "Mylan Inc", "is_major": "N"}, {"rank": "3", "name": "organizations", "value": "Meda AB", "is_major": "N"}, {"rank": "4", "name": "organizations", "value": "Perrigo Company", "is_major": "N"}, {"rank": "5", "name": "organizations", "value": "Teva Pharmaceutical Industries Ltd", "is_major": "N"}, {"rank": "6", "name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "N"}]}